We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Servier Laboratories Ireland Ltd

Block 2, West Pier Business Campus, Old Dunleary Road, Dun Laoghaire, Co. Dublin,
Telephone: +353 1 663 8110
Fax: +353 1 663 8120
Patient Information Leaflet last updated on medicines.ie: 11/10/2017
PIL Valdoxan 25mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/10/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - what the product looks like and pack contents
Updated on 07/12/2016 and displayed until 11/10/2017
Reasons for adding or updating:
  • Change to section 4 - possible side effects
Updated on 23/11/2015 and displayed until 07/12/2016
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 19/12/2014 and displayed until 23/11/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/07/2014 and displayed until 19/12/2014
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 13/02/2014 and displayed until 08/07/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 17/09/2013 and displayed until 13/02/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 08/11/2012 and displayed until 17/09/2013
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 04/04/2012 and displayed until 08/11/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/02/2012 and displayed until 04/04/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/09/2011 and displayed until 15/02/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 07/02/2011 and displayed until 05/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
  • Change to side-effects
Updated on 10/09/2010 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 03/12/2009 and displayed until 10/09/2010
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Agomelatine